General MedicationsOPHTHALMICGeneric

KETOROLAC TROMETHAMINE

Standard Dose

0.4%

Max Dose

Refer to approved labeling

Primary Use

Review priority: STANDARD Marketing status: Discontinued

Summary

Approval overview KETOROLAC TROMETHAMINE is listed in Drugs@FDA under application 205191 (ANDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient KETOROLAC TROMETHAMINE Form and strength SOLUTION/DROPS;OPHTHALMIC - 0.4% Sponsor EUGIA PHARMA Submission history Latest submission status date: 2024-03-29 00:00:00.

Structured Monograph

Clinical summary

Approval overview KETOROLAC TROMETHAMINE is listed in Drugs@FDA under application 205191 (ANDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient KETOROLAC TROMETHAMINE Form and strength SOLUTION/DROPS;OPHTHALMIC - 0.4% Sponsor EUGIA PHARMA Submission history Latest submission status date: 2024-03-29 00:00:00. Submission type: SUPPL.

Monitoring

• Marketing status: Discontinued
• Review priority: STANDARD

Interaction Notes

No interaction notes stored yet.